18 articles, transcripts, and reports
ImmunoGen Inc (NASDAQ:IMGN) Q1 2023 Earnings Call dated Apr. 28, 2023. Corporate Participants: Anabel Chan — Head, Investor Relations Mark Enyedy — President & Chief Executive Officer Anna Berkenblit — Senior…
ImmunoGen Inc (NASDAQ:IMGN) Q4 2022 Earnings Call dated Mar. 01, 2023. Corporate Participants: Anabel Chan — Head of Investor Relations Mark Enyedy — President and Chief Executive Officer Anna…
ImmunoGen, Inc. (NASDAQ: IMGN) Q2 2022 earnings call dated Jul. 29, 2022 Corporate Participants: Anabel Chan — Head of Investor Relations Mark Enyedy — President & Chief Executive Officer…
ImmunoGen, Inc. (NASDAQ: IMGN) Q1 2022 earnings call dated May. 06, 2022 Corporate Participants: Courtney O’Konek — Senior Director of Corporate Communications Mark Enyedy — President & Chief Executive…
ImmunoGen, Inc. (NASDAQ: IMGN) FY 2021 earnings call dated Feb. 25, 2022 Corporate Participants: Courtney O’Konek — Senior Director of Corporate Communications and Investor Relations Mark Enyedy — President…
ImmunoGen Inc. (NASDAQ: IMGN) Q2 2021 earnings call dated Jul. 30, 2021 Corporate Participants: Courtney O’Konek — Senior Director of Corporate Communications and Investor Relations Mark Enyedy — President…
Immunogen, Inc. (NASDAQ: IMGN) Q1 2021 earnings call dated May. 10, 2021 Corporate Participants: Courtney O’Konek — Senior Director of Corporate Communications and Investor Relations Mark Enyedy — President…
ImmunoGen Inc. (NASDAQ: IMGN) last week reported a profit after incurring losses in the first three quarters of last year. The surprise earnings added to…
ImmunoGen Inc. (NASDAQ: IMGN) Q4 2020 earnings call dated Feb. 12, 2021 Corporate Participants: Courtney O’Konek — Senior Director of Corporate Communications and Investor Relations Mark Enyedy — President…
Immunogen Inc (NASDAQ: IMGN) Q3 2020 earnings call dated Nov. 06, 2020 Corporate Participants: Courtney O’Konek — Senior Director of Corporate Communications and Investor Relations Mark Enyedy — President…
